POSTER SESSION V Wednesday, February 15, 2006   —  9:30 AM - 12:00 Noon Exhibit Level PULMONARY PATHOLOGY 164 Metastic Granulosa Cell Tumor Of The Lung: Clinicopathologic Study Of 7 Cases (1446) S Jung, JT Lewis, GL Keeney - Mayo Clinic, Rochester, MN 165 D2-40 Expression In Minute Pulmonary Meningothelioid Nodules (1468) HR Peterman, LA Litzky, TL Pasha, PJ Zhang - Hospital of the University of Pennsylvania, Philadelphia, PA 166 Beta-Catenin and Estrogen-Receptor Beta Expression in Pulmonary Meningothelial-Like Nodules: Another Link in the "BROCN" Family of Lesions? (1428) A Frey, O Basturk, V Pansare, C Moran, JD Cheng, NV Adsay - Wayne State University-Karmanos Cancer Institute, MI; UT MD Anderson Cancer Center, TX 167 Pneumocytic Adenomyoepithelioma (1420) T Chang, AN Husain, T Colby, J Taxy, W Welch, S Cheung, A Early, W Travis, T Krausz - University of Chicago, Chicago, IL; Mayo Clinic, Scottsdale, AR; Brigham and Women's Hospital, Boston, MA; Queen Elizabeth Hospital, Hong Kong, China; Southern Regional Medical Center, Riverdale, GA; Memorial Sloan Kettering Cancer Center, New York, NY 168 COX-2 And Angiogenic Factors In Neuroendocrine Lung Tumors (1404) FI Aranda, G Peiro, M Niveiro, C Alenda, M Planelles, A Teruel - Hospital General Universitario, Alicante, Spain 169 Evaluation of Expression Characteristics of P-Akt, Pax-5, Ship-1, ALK-1 and TGF-² Protein Molecules in Pulmonary Neuroendocrine Tumors (NT) (1453) KY Kwon, N Singhal, L Garza, DE Killen, A Sienko, JY Ro, PT Cagle - Keimyung University School of Medicine, Daegu, Korea; The Methodist Hospital, Houston, TX 170 Vitamin D Receptor and Steroid Receptor Coactivator-1 Expression in Pulmonary Neuroendocrine Neoplasms (1452) UR Kundu, J Liu, DS Zander, AE Sienko, RJ Barrios, AK Haque, TC Allen, CY Castro, NA Singhal, PT Cagle - UTHSC-Houston Medical School, The Methodist Hospital, Houston, TX; Univ of Texas Health Center, Tyler, TX; Univ of Texas Medical Branch, Galveston, TX 171 FGF-2 Expression Correlates with Tumor Grade in Pulmonary Neuroendocrine Neoplasms (1472) MA Sajid, DS Zander, W Li, RJ Barrios, NA Singhal, TC Allen, CY Castro, AK Haque, AE Sienko, PT Cagle - UTHSC-Houston Medical School, The Methodist Hospital, Houston, TX; Univ of Texas Health Center, Tyler, TX; Univ of Texas Medical Branch, Galveston, TX 172 Diffuse Pulmonary Neuroendocrine (NE) Cell Hyperplasia, Tumorlets And Carcinoid Tumors: A Clinicopathologic Study Of 22 Cases (1413) N Boroumand, TJ Franks, DS Klimstra, MF Zakowski, AL Moreira, K Shilo, WD Travis - Memorial Sloan Kettering Cancer Center, New York, NY; Armed Forces Institute of Path., Washington, DC 173 Pulmonary Neuroendocrine Tumors Can Express Markers of Myoepithelial and Salivary Duct Differentiation (1436) EM Gomez, D Tan, DS Zander, AK Haque, CY Castro, TC Allen, AE Sienko, RJ Barrios, NA Singhal, PT Cagle - UTHSC-Houston Medical School, The Methodist Hospital, Houston, TX; Univ of Texas Medical Branch, Galveston, TX; Univ of Texas Health Center, Tyler, TX 174 Immunohistochemical Analysis of Glutathione S-Transferase alpha and Insulin Growth Factor Binding Protein-3 in Primary Pulmonary Adenocarcinoma. (1440) MA Havens, AV Yeldandi, XJ Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL 175 Telomere Length And Telomerase Expression In Small Non-Mucinous Bronchioloalveolar Carcinoma (BAC) Of The Lung (1448) T Kawai, S Hiroi, S Tominaga, K Nakanishi - National Defense Medical College, Tokorozawa, Saitama, Japan 176 Immunohistochemical Analysis of Potential Cell signaling Biomarkers for Mutant Epidermal Growth Factor Receptor (1491) QF Zeng, K Crosby, AL Guo, K Rilkova, BL Smith, R Polakiewicz - Cell Signaling Technology, Beverly, MA 177 Characterization of Epidermal Growth Factor Receptor (EGFR) Gene Copy Number by Chromogenic In Situ Hybridization (CISH) in Atypical Adenomatous Hyperplasia, Bronchioloalveolar Carcinoma and Adenocarcinoma of the Lung (1423) LR Chirieac, S Santagata, KL Ligon - Brigham and Women's Hospital, Boston, MA 178 Epidermal Growth Factor Receptor in Non Small Cell Lung Cancer: Gene Copy Number and Mutational Study (1424) A Colomer, N Erill, M Verdú, R Roman, M Górriz, A Menoyo, R IbáZez, C Cordon-Cardo, X Puig - Grup AssistPncia, Barcelona, Catalonia, Spain; Barcelona, Catalonia, Spain; Memorial Sloan Kettering Cancer Center, New York, NY 179 Performance Characteristics For A Diagnostic Molecular Test For EGFR Gene Mutations, KRAS Mutations, And EGFR Amplification In Lung Adenocarcinomas (1415) D Caglar, S Dacic, GS Mantha, JL Hunt - University of Pittsburgh, Pittsburgh, PA 180 Evaluation of Alpha-Methyacyl-CoenzymeA racemase(AMACR) Expression In Pulmonary Bronchioloalveolar Adenocarcinomas. (1482) HS Strawn, CG Deshpande, SM Sitterding, XJ Yang, AV Yeldandi - Feinberg School of Medicine, Northwestern University, Chicago, IL 181 Gene Expression Profiling Of Microdissected Pulmonary Adenocarcinoma And Bronchioloalveolar Carcinoma (1408) LC Beck, CA Powell, AC Borczuk - Columbia University Medical Center, New York, NY 182 Loss of Expression of MLH1 and BRCA2 Is Associated With Progression of Lung Adenocarcinoma (1434) S Giashuddin, H Yee, D Chang, L Chiriboga, R Arju, J Yim - New York University School of Medicine, New York, NY 183 A Lung Adenocarcinoma Molecular Subtype Associated With Non-Smokers And EGFR Mutations. (1461) N Motoi, J Szoke, MF Zakowski, WD Travis, WL Gerald - Memorial Sloan-Kettering Cancer Center, New York, NY 184 Detection Of EGFR And Her2 Activating Mutations In Lung Adenocarcinoma By High Resolution Melting Amplicon Analysis (1489) C Willmore-Payne, JA Holden, LJ Layfield - University of Utah Health Sciences Center, Salt Lake City, UT